Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Krell

Showing results (121-130 of 135) with videos related to

Pageof 14
Sort By:
Gynecologic Oncology|October 15, 2023
A randomized phase 2 study of sapanisertib in combination with paclitaxel versus paclitaxel alone in women with advanced, recurrent, or persistent endometrial cancerSileny N Han, Amit Oza, Nicoletta Colombo, et al.
International Journal of Molecular Sciences|December 9, 2023
Bile Microbiome Signatures Associated with Pancreatic Ductal Adenocarcinoma Compared to Benign Disease: A UK Pilot StudyNabeel Merali, Tarak Chouari, Julien Terroire, et al.
Nature Communications|May 12, 2018
TGF-β induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling PDAC progressionSilvia Ottaviani, Justin Stebbing, Adam E Frampton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2022
The Genomic Landscape of Early-Stage Ovarian High-Grade Serous CarcinomaZhao Cheng, Hasan Mirza, Darren P Ennis, et al.
Nature Communications|August 16, 2019
Author Correction: TGF-β induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling PDAC progressionSilvia Ottaviani, Justin Stebbing, Adam E Frampton, et al.
Journal for Immunotherapy of Cancer|March 17, 2022
Recommendations for standardizing biopsy acquisition and histological assessment of immune checkpoint inhibitor-associated colitisChristopher Ma, Rish K Pai, David F Schaeffer, et al.
Cell Reports. Medicine|May 23, 2023
Spatial and temporal intra-tumoral heterogeneity in advanced HGSOC: Implications for surgical and clinical outcomesPaula Cunnea, Edward W Curry, Elizabeth L Christie, et al.
JAMA Oncology|March 17, 2023
Efficacy and Safety of Weekly Paclitaxel Plus Vistusertib vs Paclitaxel Alone in Patients With Platinum-Resistant Ovarian High-Grade Serous Carcinoma: The OCTOPUS Multicenter, Phase 2, Randomized Clinical TrialSusana Banerjee, Gaia Giannone, Andrew R Clamp, et al.
Gastroenterology|October 15, 2013
MicroRNAs cooperatively inhibit a network of tumor suppressor genes to promote pancreatic tumor growth and progressionAdam E Frampton, Leandro Castellano, Teresa Colombo, et al.
International Journal of Surgery (London, England)|July 23, 2024
MicroRNAs as Bile-based biomarkers in pancreaticobiliary cancers (MIRABILE): a cohort studyDaniel S K Liu, Jisce R Puik, Morten T Venø, et al.
Pageof 14

Showing results (121-130 of 135) with videos related to

Sort By:
Pageof 14
Gynecologic Oncology|October 15, 2023
A randomized phase 2 study of sapanisertib in combination with paclitaxel versus paclitaxel alone in women with advanced, recurrent, or persistent endometrial cancerSileny N Han, Amit Oza, Nicoletta Colombo, et al.
International Journal of Molecular Sciences|December 9, 2023
Bile Microbiome Signatures Associated with Pancreatic Ductal Adenocarcinoma Compared to Benign Disease: A UK Pilot StudyNabeel Merali, Tarak Chouari, Julien Terroire, et al.
Nature Communications|May 12, 2018
TGF-β induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling PDAC progressionSilvia Ottaviani, Justin Stebbing, Adam E Frampton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2022
The Genomic Landscape of Early-Stage Ovarian High-Grade Serous CarcinomaZhao Cheng, Hasan Mirza, Darren P Ennis, et al.
Nature Communications|August 16, 2019
Author Correction: TGF-β induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling PDAC progressionSilvia Ottaviani, Justin Stebbing, Adam E Frampton, et al.
Journal for Immunotherapy of Cancer|March 17, 2022
Recommendations for standardizing biopsy acquisition and histological assessment of immune checkpoint inhibitor-associated colitisChristopher Ma, Rish K Pai, David F Schaeffer, et al.
Cell Reports. Medicine|May 23, 2023
Spatial and temporal intra-tumoral heterogeneity in advanced HGSOC: Implications for surgical and clinical outcomesPaula Cunnea, Edward W Curry, Elizabeth L Christie, et al.
JAMA Oncology|March 17, 2023
Efficacy and Safety of Weekly Paclitaxel Plus Vistusertib vs Paclitaxel Alone in Patients With Platinum-Resistant Ovarian High-Grade Serous Carcinoma: The OCTOPUS Multicenter, Phase 2, Randomized Clinical TrialSusana Banerjee, Gaia Giannone, Andrew R Clamp, et al.
Gastroenterology|October 15, 2013
MicroRNAs cooperatively inhibit a network of tumor suppressor genes to promote pancreatic tumor growth and progressionAdam E Frampton, Leandro Castellano, Teresa Colombo, et al.
International Journal of Surgery (London, England)|July 23, 2024
MicroRNAs as Bile-based biomarkers in pancreaticobiliary cancers (MIRABILE): a cohort studyDaniel S K Liu, Jisce R Puik, Morten T Venø, et al.
Pageof 14